Home/Filings/4/0001078782-20-000610
4//SEC Filing

Micallef Jacob Vincent 4

Accession 0001078782-20-000610

CIK 0000093314other

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 3:28 PM ET

Size

15.4 KB

Accession

0001078782-20-000610

Insider Transaction Report

Form 4
Period: 2020-08-10
Micallef Jacob Vincent
Chief Scientific Officer
Transactions
  • Tax Payment

    Common Stock

    2020-08-10$3.50/sh55,158$193,05396,008 total
  • Exercise/Conversion

    Common Stock

    2020-08-10$3.00/sh+65,000$195,000161,008 total
  • Tax Payment

    Common Stock

    2020-08-10$3.50/sh60,080$210,280100,928 total
  • Exercise/Conversion

    Common Stock

    2020-08-10$2.50/sh+65,000$162,500151,166 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-08-1065,0000 total
    Exercise: $2.50From: 2015-02-18Exp: 2020-08-18Common Stock (65,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-08-1065,0000 total
    Exercise: $3.00From: 2016-02-18Exp: 2020-08-18Common Stock (65,000 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    22,000
  • Common Stock

    (indirect: By Borlaug Limited)
    38,113
Footnotes (2)
  • [F1]Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction.
  • [F2]The shares of common stock are held directly by Borlaug Limited. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited.

Issuer

VOLITIONRX LTD

CIK 0000093314

Entity typeother

Related Parties

1
  • filerCIK 0001651671

Filing Metadata

Form type
4
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 3:28 PM ET
Size
15.4 KB